The Up-LIFT Study of Non-Invasive ARC Therapy for Spinal Cord Injury
Up-LIFT
Clinical Assessment of Upper Extremity Performance in Individuals With Spinal Cord Injury Using the LIFT System to Deliver Non-invasive Electrical Spinal Stimulation (ARC Therapy)
2 other identifiers
interventional
65
4 countries
14
Brief Summary
The Up-LIFT Study is a prospective, single-arm study designed to evaluate the safety and effectiveness of non-invasive electrical spinal cord stimulation (ARC Therapy) administered by the LIFT System to treat upper extremity functional deficits in people with chronic tetraplegia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2021
14 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 4, 2020
CompletedFirst Posted
Study publicly available on registry
January 6, 2021
CompletedStudy Start
First participant enrolled
January 8, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 13, 2022
CompletedSeptember 16, 2022
September 1, 2022
1.5 years
December 4, 2020
September 15, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Incidence of serious adverse events (SAEs)
Safety demonstrated through observational data regarding the incidence of serious adverse events (SAEs) related to the use of the study device and treatment procedures will be reported.
Through completion of the study, an average of 16 months
Number of participants with change in upper extremity strength and function
Change in upper extremity strength and function performance metrics after treatment with ARC Therapy administered by the LIFT System and Functional Task Practice (FTP) is assessed using ISNCSCI, GRASSP,CUE-T, pinch/grasp forces. The primary effectiveness outcome measure will test the hypothesis that a majority of the subjects will experience clinically significant improvement in UE performance metrics (defined as therapy responders) after treatment with ARC Therapy administered by the LIFT System and Functional Task Practice (FTP).
Through completion of the study, an average of 16 months
Secondary Outcomes (1)
Superiority of combined FTP and ARC Therapy with LIFT vs. FTP alone.
Through completion of the study, an average of 16 months
Study Arms (1)
Functional task practice (FTP) followed by FTP + ARC Therapy
EXPERIMENTALClinic-based functional task practice (FTP) for two months followed by FTP + ARC Therapy for an additional 2 months.
Interventions
The LIFT System delivers the ARC Therapy to improve upper extremity function in individuals with tetraplegia.
Eligibility Criteria
You may qualify if:
- Subjects must meet all the following criteria:
- At least 22 years old and no older than 75 years old at the time of enrollment
- Non-progressive cervical spinal cord injury from C2-C8 inclusive
- American Spinal Injury Association (ASIA) Impairment Scale (AIS) classification B, C, or D
- Indicated for upper extremity training procedures by subject's treating physician or a physical therapist
- Minimum 12 months post-injury
- Capable of providing informed consent
You may not qualify if:
- Subjects must not meet any of the following criteria:
- Has uncontrolled cardiopulmonary disease or cardiac symptoms as determined by the Investigator
- Has any unstable or significant medical condition that is likely to interfere with study procedures or likely to confound study endpoint evaluations like severe neuropathic pain, depression, mood disorders or other cognitive disorders
- Has been diagnosed with autonomic dysreflexia that is severe, unstable, and uncontrolled
- Requires ventilator support
- Has an autoimmune etiology of spinal cord dysfunction/injury
- Spasms that limit the ability of the subjects to participate in the study training as determined by the Investigator
- Breakdown in skin area that will come into contact with electrodes
- Has any active implanted medical device
- Pregnant, planning to become pregnant or currently breastfeeding
- Concurrent participation in another drug or device trial that may interfere with this study
- In the opinion of the investigators, the study is not safe or appropriate for the participant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (14)
Craig Hospital
Englewood, Colorado, 80113, United States
Miller School of Medicine, The Miami Project to Cure Paralysis
Miami, Florida, 33136, United States
Shepherd Center- Crawford Research Institute
Atlanta, Georgia, 30303, United States
INSPIRE Laboratory, Spaulding Hospital
Cambridge, Massachusetts, 02138, United States
University of Minnesota
Minneapolis, Minnesota, 55441, United States
Mayo Clinic
Rochester, Minnesota, 55905, United States
James J. Peters VA Medical Center
The Bronx, New York, 10468, United States
Thomas Jefferson University/Magee Rehabilitation Hospitals
Philadelphia, Pennsylvania, 19107, United States
University of Washington
Seattle, Washington, 98195, United States
International Collaboration on Repair Discoveries (ICORD), University of British Columbia
Vancouver, British Columbia, V5Z 1M9, Canada
KITE Research Institute /University Health Network
Toronto, Ontario, M4G 3V9, Canada
Sint Maartenskliniek, Department of Rehabilitation
Nijmegen, Gelderland, 6574, Netherlands
Reade, Centre for Rehabilitation and Rheumatology
Amsterdam, North Holland, 1054 HW, Netherlands
Queen Elizabeth National Spinal Injuries Unit
Glasgow, G51 4TF, United Kingdom
Related Publications (3)
Inanici F, Samejima S, Gad P, Edgerton VR, Hofstetter CP, Moritz CT. Transcutaneous Electrical Spinal Stimulation Promotes Long-Term Recovery of Upper Extremity Function in Chronic Tetraplegia. IEEE Trans Neural Syst Rehabil Eng. 2018 Jun;26(6):1272-1278. doi: 10.1109/TNSRE.2018.2834339.
PMID: 29877852BACKGROUNDHoffman L, Field-Fote E. Effects of practice combined with somatosensory or motor stimulation on hand function in persons with spinal cord injury. Top Spinal Cord Inj Rehabil. 2013 Fall;19(4):288-99. doi: 10.1310/sci1904-288.
PMID: 24244094BACKGROUNDMoritz C, Field-Fote EC, Tefertiller C, van Nes I, Trumbower R, Kalsi-Ryan S, Purcell M, Janssen TWJ, Krassioukov A, Morse LR, Zhao KD, Guest J, Marino RJ, Murray LM, Wecht JM, Rieger M, Pradarelli J, Turner A, D'Amico J, Squair JW, Courtine G. Non-invasive spinal cord electrical stimulation for arm and hand function in chronic tetraplegia: a safety and efficacy trial. Nat Med. 2024 May;30(5):1276-1283. doi: 10.1038/s41591-024-02940-9. Epub 2024 May 20.
PMID: 38769431DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Edelle Field-Fote, PT, PhD
Shepherd Center - Crawford Research Institute
- PRINCIPAL INVESTIGATOR
Chet Moritz, PhD
University of Washington
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 4, 2020
First Posted
January 6, 2021
Study Start
January 8, 2021
Primary Completion
June 30, 2022
Study Completion
September 13, 2022
Last Updated
September 16, 2022
Record last verified: 2022-09
Data Sharing
- IPD Sharing
- Will not share